Medical Care
- Net sales in 2010: EUR 1,514 million
- Headquarters: Tarrytown, New York (USA)
Bayer HealthCare’s Medical Care Division is one of the leading providers of blood glu-cose monitoring systems and medical devices. Its portfolio includes blood glucose moni-toring systems, monitors to test glycated hemoglobin (HbA1c), Viterion TeleHealth and other patient education and lifestyle support services. The division also markets devices for diagnostic imaging and medical therapy.
The portfolio of blood glucose meters includes Contour, Contour TS, Contour Link, Con-tour USB, Didget and Breeze2. In 2010, the division continued the global rollout of the Contour USB meter which connects directly to a computer, providing users with easy access to information and trends about their blood sugar levels. Monitors for measurement of glycated hemoglobin include the A1CNOW+ monitor for healthcare providers, and A1CNOW SELFCHECK for home use. Glycated hemoglobin is an indicator of long-term blood sugar control. Viterion TeleHealth provides remote patient monitoring technology to help manage chronic conditions such as diabetes and congestive heart failure.
Moreover, Medical Care develops, markets and services medical devices that enable or enhance therapeutic medical procedures in computed tomography, magnetic resonance imaging, molecular imaging and cardiovascular applications. Its products include fluid injection systems for radiology and cardiology, vascular intervention systems for treating constricted or blocked blood vessels, magnetic-resonance-compatible accessories and equipment services. Fluid delivery systems are used to enhance computed tomography (CT), positron emission tomography (PET), magnetic resonance imaging (MRI) and an-giography/cardiovascular imaging procedures. In 2010, the division’s medical devices business was recognized for the second time with the Malcolm Baldrige National Quality Award, the highest honor a U.S. company can receive for quality and business excellence.
Moreover, Medical Care develops, markets and services medical devices that enable or enhance therapeutic medical procedures in computed tomography, magnetic resonance imaging, molecular imaging and cardiovascular applications. Its products include fluid injection systems for radiology and cardiology, vascular intervention systems for treating constricted or blocked blood vessels, magnetic-resonance-compatible accessories and equipment services. Fluid delivery systems are used to enhance computed tomography (CT), positron emission tomography (PET), magnetic resonance imaging (MRI) and an-giography/cardiovascular imaging procedures. In 2010, the division’s medical devices business was recognized for the second time with the Malcolm Baldrige National Quality Award, the highest honor a U.S. company can receive for quality and business excellence.
Medrad
Medrad develops, markets and services medical devices that enable or enhance therapeutic medical procedures in computed tomography, magnetic resonance imaging, molecular imaging and cardiovascular applications. Its products include fluid injection systems for radiology and cardiology, vascular intervention systems for treating constricted or blocked blood vessels, magnetic-resonance-compatible accessories and equipment services. Fluid delivery systems are used to enhance computed tomography (CT), positron emission tomography (PET), magnetic resonance imaging (MRI) and angiography/cardiovascular imaging procedures.
Search
Bayer HealthCare Links
Financial Report
